Compositions and Methods for the Treatment of Sexual Dysfunctions

A composition for treating a reduced amount of tactile sexual function, comprising:

• at least one positive GABAergic treatment substance, wherein the at least one positive GABAergic treatment substance increases the amount of a GABAA receptor agonist after the person ingests the at least one positive GABAergic treatment substance;
• and
• at least one negative glutamatergic treatment substance, at least another positive GABAergic treatment substance, or a combination thereof;
• wherein the at least one positive GABAergic treatment substance comprises at least one precursor of GABA, at least one GABA prodrug, at least one GABAA receptor agonist, or a combination thereof;
• wherein the at least one negative glutamatergic treatment substance promotes the activation of the mGlu2 receptor, the mGlu3 receptor, or a combination thereof;
• and wherein the at least another positive GABAergic treatment substance activates a TRPV1-Receptor and activates a KCC2 transporter;
• wherein the at least one positive GABAergic treatment substance and the at least one negative glutamatergic treatment substance, at least another positive GABAergic treatment substance, or a combination thereof, are in an effective amount to achieve pleasurable tactile sexual function just before the beginning of orgasm, just after the beginning of orgasm, or both, in a person.